Correlation
The correlation between UTHR and SRPT is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
UTHR vs. SRPT
Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Sarepta Therapeutics, Inc. (SRPT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTHR or SRPT.
Performance
UTHR vs. SRPT - Performance Comparison
Loading data...
Key characteristics
UTHR:
0.62
SRPT:
-0.95
UTHR:
0.91
SRPT:
-1.65
UTHR:
1.13
SRPT:
0.74
UTHR:
0.54
SRPT:
-0.86
UTHR:
1.20
SRPT:
-1.86
UTHR:
14.55%
SRPT:
36.96%
UTHR:
31.71%
SRPT:
70.23%
UTHR:
-93.18%
SRPT:
-98.17%
UTHR:
-21.86%
SRPT:
-78.40%
Fundamentals
UTHR:
$14.45B
SRPT:
$3.66B
UTHR:
$25.47
SRPT:
-$2.64
UTHR:
1.43
SRPT:
159.25
UTHR:
4.83
SRPT:
1.64
UTHR:
2.09
SRPT:
3.20
UTHR:
$2.99B
SRPT:
$2.23B
UTHR:
$2.66B
SRPT:
$1.81B
UTHR:
$1.56B
SRPT:
-$117.73M
Returns By Period
In the year-to-date period, UTHR achieves a -9.20% return, which is significantly higher than SRPT's -68.25% return. Over the past 10 years, UTHR has outperformed SRPT with an annualized return of 5.81%, while SRPT has yielded a comparatively lower 4.46% annualized return.
UTHR
-9.20%
6.52%
-15.28%
19.67%
10.75%
22.12%
5.81%
SRPT
-68.25%
-36.55%
-72.01%
-66.79%
-19.73%
-24.00%
4.46%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UTHR vs. SRPT — Risk-Adjusted Performance Rank
UTHR
SRPT
UTHR vs. SRPT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
UTHR vs. SRPT - Dividend Comparison
Neither UTHR nor SRPT has paid dividends to shareholders.
Drawdowns
UTHR vs. SRPT - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, smaller than the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for UTHR and SRPT.
Loading data...
Volatility
UTHR vs. SRPT - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 8.07%, while Sarepta Therapeutics, Inc. (SRPT) has a volatility of 40.27%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
UTHR vs. SRPT - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. SRPT - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, United Therapeutics Corporation reported a gross profit of 701.90M and revenue of 794.40M. Therefore, the gross margin over that period was 88.4%.
SRPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported a gross profit of 607.29M and revenue of 744.86M. Therefore, the gross margin over that period was 81.5%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, United Therapeutics Corporation reported an operating income of 382.80M and revenue of 794.40M, resulting in an operating margin of 48.2%.
SRPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported an operating income of -300.39M and revenue of 744.86M, resulting in an operating margin of -40.3%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, United Therapeutics Corporation reported a net income of 322.20M and revenue of 794.40M, resulting in a net margin of 40.6%.
SRPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported a net income of -447.51M and revenue of 744.86M, resulting in a net margin of -60.1%.